Keyphrases
Israeli
100%
Center Experience
100%
Hepatitis C
100%
Hemophilia
100%
Sustained Viral Response
100%
Haemophilia Treatment Centre
100%
Pegylated Interferon
57%
Hemophilia Patients
57%
Ribavirin
42%
Nave
28%
Bleeding Episodes
28%
Co-infected Patients
28%
Anemia
14%
Infected Patients
14%
Interferon-α (IFN-α)
14%
Observational Cohort Study
14%
Standard of Care
14%
Expected Rate
14%
HIV Patients
14%
Relapse Rate
14%
Non-responders
14%
Growth Factors
14%
Erythropoietin
14%
Hemoglobin Level
14%
Severe Anemia
14%
Ribavirin Treatment
14%
Genotype 1
14%
Standard Interferon
14%
Nonresponse Rate
14%
Medicine and Dentistry
Hepatitis C
100%
Patient with Hemophilia
100%
Haemophilia
100%
Human Immunodeficiency Virus
66%
Ribavirin
66%
Peginterferon
66%
Anemia
33%
Interferon
33%
Bleeding
16%
Side Effect
16%
Cohort Study
16%
Recurrence Risk
16%
Growth Factor
16%
Erythropoietin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
100%
Haemophilia
100%
HIV
57%
Ribavirin
57%
Peginterferon
57%
Anemia
28%
Interferon
28%
Growth Factor
14%
Cohort Study
14%
Bleeding
14%
Side Effect
14%
Recurrence Risk
14%
Erythropoietin
14%